APA Zitierstil

Qi, D., Liu, H., Sun, X., Luo, D., Zhu, M., Tao, T., . . . Xiao, J. (2021). Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss. Front Pharmacol.

Chicago Zitierstil

Qi, Dahu, et al. "Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss." Front Pharmacol 2021.

MLA Zitierstil

Qi, Dahu, et al. "Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss." Front Pharmacol 2021.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.